ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Freenome, Inc.
14.37
-0.4200
-2.84%
盤後：
14.65
0.2800
+1.95%
19:30 EDT
成交量：
53.85萬
成交額：
784.81萬
市值：
15.38億
市盈率：
-208.26
高：
15.14
開：
14.85
低：
14.37
收：
14.79
52周最高：
17.18
52周最低：
9.95
股本：
1.07億
流通股本：
6,847.72萬
量比：
0.82
換手率：
0.79%
股息：
- -
股息率：
- -
每股收益(TTM):
-0.0690
每股收益(LYR):
-8.2800
淨資產收益率：
--
總資產收益率：
--
市淨率：
-1.11
市盈率(LYR):
-1.74
資料載入中...
總覽
公司
新聞
公告
公司資料
公司名字：
Freenome, Inc.
交易所：
NASDAQ
成立時間：
2014
員工人數：
378
公司地址：
3300 Marina Boulevard,Brisbane,California,United States
官網：
http://www.freenome.com
郵編：
94005
電話：
(650) 446-6630
傳真：
- -
簡介：
Freenome, Inc.於2024年3月22日在開曼群島註冊成立，並於2026年7月21日在特拉華州重新註冊成立。該公司是一家處於研發階段的早期癌症檢測公司，致力於開發基於血液的篩查測試，利用其專有的人工智能和機器學習多組學技術平台，以變革多種癌症乃至最終多種疾病的檢測方式。該公司正在開發一系列基於血液的癌症篩查測試，包括已向美國食品藥品監督管理局（FDA）提交上市前審批申請的主導產品、改進版本以及基於血液的肺癌檢測。Freenome還啟動了一項臨床研究，以支持其肺癌檢測的監管申請。
董事
名稱
職位
Aaron Elliott
Chief Executive Officer and Director
Ann Costello
Director
Carole Nuechterlein
Director
Deepika Pakianathan
Director
Douglas M. VanOort
Director
Peter Kolchinsky
Director
Randal Scott
Director
股東
名稱
職位
Aaron Elliott
Chief Executive Officer and Director
Linh H. Le
Chief Financial Officer
Cheng Ho Jimmy Lin
Chief Scientific Officer
Riley Ennis
Chief Product Officer
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/FRNM/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FRNM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FRNM\",,,,,undefined,":{"symbol":"FRNM","market":"US","secType":"STK","nameCN":"Freenome, Inc.","latestPrice":14.37,"timestamp":1789156800000,"preClose":14.79,"halted":0,"volume":538461,"hourTrading":{"tag":"盘后","latestPrice":14.65,"preClose":14.37,"latestTime":"19:30 EDT","volume":4255,"amount":61908.33,"timestamp":1789169404730,"change":0.28,"changeRate":0.019485,"amplitude":0.019485},"delay":0,"changeRate":-0.02839756592292089,"floatShares":68477200,"shares":107000000,"eps":-0.069,"marketStatus":"休市中","change":-0.42,"latestTime":"09-11 16:00:00 EDT","open":14.85,"high":15.1383,"low":14.37,"amount":7848051.8442480005,"amplitude":0.051947,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.069,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1718164800000,"exchange":"NASDAQ","adjPreClose":14.79,"preHourTrading":{"tag":"盘前","latestPrice":15.3,"preClose":14.79,"latestTime":"09:28 EDT","volume":84,"amount":1278.899916,"timestamp":1789133280065,"change":0.51,"changeRate":0.034483,"amplitude":0.010142},"postHourTrading":{"tag":"盘后","latestPrice":14.65,"preClose":14.37,"latestTime":"19:30 EDT","volume":4255,"amount":61908.33,"timestamp":1789169404730,"change":0.28,"changeRate":0.019485,"amplitude":0.019485},"volumeRatio":0.8217408863169942},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FRNM\",,,,,undefined,":{"symbol":"FRNM","floatShares":68477200,"roa":"--","roe":"--","lyrEps":-8.279999,"volumeRatio":0.8217408863169942,"shares":107000000,"dividePrice":0,"high":15.1383,"amplitude":0.051947,"preClose":14.79,"low":14.37,"week52Low":9.95,"pbRate":"-1.11","psRate":"43.42","week52High":17.175,"institutionHeld":0,"latestPrice":14.37,"eps":-0.069,"divideRate":0,"volume":538461,"delay":0,"ttmEps":-0.069,"open":14.85,"prevYearClose":13.03,"prevWeekClose":16.31,"prevMonthClose":14.79,"prevQuarterClose":10.88,"fiveDayClose":16.9,"twentyDayClose":11.61,"sixtyDayClose":11.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FRNM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-15","symbol":"FRNM","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1784088000000,"reportTimeType":"pre","actualEps":-0.01}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FRNM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FRNM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":3,"updateTime":1787284800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FRNM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FRNM","date":"2026-09-11","current":-208.26087,"percent":0.25,"low":-7.716322,"twenty":-6.811745,"median":-6.305468,"eighty":-5.549902,"high":-5.010259,"avg":-6.253452,"sd":0.716867,"marketCap":1589138379},"quantilePoints":[{"date":"2026-07-31","current":-5.010259,"twenty":-5.523823,"median":-5.223408,"eighty":-5.031323,"marketCap":1127448482},{"date":"2026-08-07","current":-5.471664,"twenty":-5.549902,"median":-5.471664,"eighty":-5.259016,"marketCap":1231277572},{"date":"2026-08-14","current":-5.822733,"twenty":-5.804678,"median":-5.556923,"eighty":-5.443578,"marketCap":1310277966},{"date":"2026-08-21","current":-6.775635,"twenty":-6.21894,"median":-5.707382,"eighty":-5.471664,"marketCap":1524707608},{"date":"2026-08-28","current":-6.364824,"twenty":-6.405917,"median":-5.810195,"eighty":-5.471664,"marketCap":1497808587},{"date":"2026-09-04","current":-7.716322,"twenty":-6.752923,"median":-6.018329,"eighty":-5.501756,"marketCap":1815851156},{"date":"2026-09-11","current":-6.752923,"twenty":-6.811745,"median":-6.305468,"eighty":-5.549902,"marketCap":1589138379}],"updateTime":1789291737936},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":558895568,"yearFounded":2014,"employeeNum":378,"address":"3300 Marina Boulevard,Brisbane,California,United States","zipCode":"94005","officePhone":"(650) 446-6630","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.freenome.com","stockEarnings":[{"period":"1week","weight":-0.1189},{"period":"1month","weight":0.2442},{"period":"3month","weight":0.2605},{"period":"6month","weight":0.2946},{"period":"1year","weight":0.3621},{"period":"ytd","weight":0.1028}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Freenome, Inc.於2024年3月22日在開曼群島註冊成立，並於2026年7月21日在特拉華州重新註冊成立。該公司是一家處於研發階段的早期癌症檢測公司，致力於開發基於血液的篩查測試，利用其專有的人工智能和機器學習多組學技術平台，以變革多種癌症乃至最終多種疾病的檢測方式。該公司正在開發一系列基於血液的癌症篩查測試，包括已向美國食品藥品監督管理局（FDA）提交上市前審批申請的主導產品、改進版本以及基於血液的肺癌檢測。Freenome還啟動了一項臨床研究，以支持其肺癌檢測的監管申請。","exchange":"NASDAQ","name":"Freenome, Inc.","nameEN":"Freenome, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"FRNM\",market:\"US\",,,undefined,":{"directors":[{"name":"Aaron Elliott","position":"Chief Executive Officer and Director"},{"name":"Ann Costello","position":"Director"},{"name":"Carole Nuechterlein","position":"Director"},{"name":"Deepika Pakianathan","position":"Director"},{"name":"Douglas M. VanOort","position":"Director"},{"name":"Peter Kolchinsky","position":"Director"},{"name":"Randal Scott","position":"Director"}],"executives":[{"name":"Aaron Elliott","position":"Chief Executive Officer and Director"},{"name":"Linh H. Le","position":"Chief Financial Officer"},{"name":"Cheng Ho Jimmy Lin","position":"Chief Scientific Officer"},{"name":"Riley Ennis","position":"Chief Product Officer"}]}}}